In addition, multivariate analysis showed that patients with high tumor EHMT2 protein expression had significantly worse 5-year overall survival compared to patients with low tumor EHMT2 expression, and this was independent of other established prognostic factors [27]. Here, EHMT2 is linked to neoplasm.